{
    "Trade/Device Name(s)": [
        "FreeStyle Connect Blood Glucose Monitoring System",
        "FreeStyle Connect\u2122M Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Abbott Laboratories / TheraSense Inc.",
    "510(k) Number": "K051802",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022941",
        "K050500"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW"
    ],
    "Summary Letter Date": "August 9, 2005",
    "Summary Letter Received Date": "August 1, 2005",
    "Submission Date": "July 29, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood",
        "Venous whole blood",
        "Arterial whole blood",
        "Neonatal whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "FreeStyle Connect Blood Glucose Monitor"
    ],
    "Method(s)/Technology(ies)": [
        "Coulometric biosensor technology",
        "Electrochemical measurement"
    ],
    "Methodologies": [
        "Quantitative measurement"
    ],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Reagent",
        "Test Strip"
    ],
    "Document Summary": "FDA 510(k) summary for FreeStyle Connect Blood Glucose Monitoring System using coulometric biosensor technology for quantitative glucose measurement in whole blood",
    "Indications for Use Summary": "Intended for in vitro diagnostic use for quantitative measurement of glucose in fresh capillary, venous, arterial, and neonatal whole blood samples in home and professional settings",
    "fda_folder": "Clinical Chemistry"
}